As of 12:33:57 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BLIGH JAMES Chief Financial Officer | Stock Award(Grant) | Jun 11, 2024 | 37,272 |
| CHARLES FAITH L. Director | Stock Award(Grant) | Nov 18, 2024 | 341,594 |
| FARLEY CHELE CHIAVACCI Director | Stock Award(Grant) | Nov 18, 2024 | 351,510 |
| HEILBRON JACK KENDRICK Former | Conversion of Exercise of derivative security | Sep 22, 2023 | -- |
| LEWIS-HALL FREDA C Director | Stock Award(Grant) | Nov 18, 2024 | 2,958,290 |
| NIRLAND LTD Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 7, 2024 | -- |
| REGAN ANDREW J. Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 17, 2024 | -- |
| SRAGOVICZ ADAM Chief Financial Officer | Stock Award(Grant) | Dec 1, 2023 | 74,545 |
Related Tickers
CERO CERo Therapeutics Holdings, Inc.
3.0300
-18.11%
CNSP CNS Pharmaceuticals, Inc.
0.1171
+0.95%
SPRC SciSparc Ltd.
0.7847
-2.72%
IMRX Immuneering Corporation
2.1300
+6.50%
MBIO Mustang Bio, Inc.
0.2520
+13.30%
SCPX Scorpius Holdings, Inc.
0.3850
+1.05%
SILO Silo Pharma, Inc.
1.8805
+9.97%
EYEN Eyenovia, Inc.
0.1051
-12.20%
BLRX BioLineRx Ltd.
0.1404
-1.54%
HOTH Hoth Therapeutics, Inc.
1.9700
+3.68%